Combinyx Services LLC was founded in 2026 by Jeff Givand, PhD, leveraging over 26 years of expertise from his distinguished career at Merck. He was most recently leading the R&D Device Development department responsible for clinical and commercial development of a large portfolio of biologics, vaccines and small molecules requiring delivery devices such as pen and auto-injectors, pre-filled syringes and needle-safety devices, on-body delivery systems, inhalers, subcutaneous implants, and intravitreal delivery devices.

Combinyx specializes in providing comprehensive technical and scientific consulting services to the pharmaceutical and biopharmaceutical industries. Our deep knowledge spans early R&D, delivery device technology selection, interactions between formulation and delivery device, product and process development, scale-up, process validation, registration and launch readiness. This breadth of experience and expertise across delivery technologies ranging from pre-filled syringes, to pen and auto-injectors, to inhalers, implantation and on-body delivery systems enables us to guide clients through every stage of product development and commercialization.

We exist to empower organizations navigating the complex landscape of drug delivery device design, development, and combination product commercialization. With specialized expertise in engineering, process development, primary container characterization, design verification and human factors considerations, we deliver strategic guidance that transforms innovative concepts into market-ready solutions for small molecules, biologics, and vaccines. We can help establish and pressure-test project timelines as well as product development strategies.